Clinical Trial Update: Avelumab With Radiotherapy in Patients With Leptomeningeal Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of avelumab with radiotherapy in patients with leptomeningeal disease/metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Disease
• Leptomeningeal Metastases

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Leptomeningeal Metastases, Leptomeningeal Disease | Phase 1 | Status: COMPLETED